Clinical Trials
3 trialsNCT05542342 2026-06-01
SITISVEAL
Grupo Español Multidisciplinar de Melanoma
Phase 2 Completed
NCT03906071 2025-10-21
SAPPHIRE
Mirati Therapeutics Inc.
Phase 3 Completed
NCT04921358 2025-06-29
Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
BeiGene
Phase 3 Terminated